Robert Kristal - Nov 3, 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Chief Financial Officer
Signature
/s/ Robert Kristal
Stock symbol
BRTX
Transactions as of
Nov 3, 2022
Transactions value $
$0
Form type
4
Date filed
11/4/2022, 04:24 PM
Previous filing
Jun 15, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BRTX Common Stock 7.99K Nov 3, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Disposed to Issuer $0 -10.5K -100% $0.00* 0 Nov 3, 2022 Common Stock 10.5K $13.50 Direct F1, F2
transaction BRTX Stock Option Award $0 +10.5K $0.00 10.5K Nov 3, 2022 Common Stock 10.5K $5.08 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.
F2 The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the "old" stock option and the grant of a "replacement" stock option with a reduced exercise price.